Provided by Tiger Fintech (Singapore) Pte. Ltd.

e.l.f. Beauty Inc.

77.63
+0.48000.62%
Volume:727.97K
Turnover:55.76M
Market Cap:4.38B
PE:46.35
High:78.17
Open:75.50
Low:74.49
Close:77.15
Loading ...

Stocks' Gains Won't Last. The Charts Say to Sell These 9. -- Barrons.com

Dow Jones
·
1 hour ago

Deutsche Bank Adjusts e.l.f. Beauty Price Target to $80 From $73, Maintains Hold Rating

MT Newswires Live
·
Yesterday

e.l.f. Beauty Expands Its Reach in The Netherlands and Belgium with Launch in KRUIDVAT and TREKPLEISTER Stores

Reuters
·
Yesterday

E.l.f. Beauty Expands Presence in the Netherlands and Belgium With Entry Into Kruidvat and Trekpleister Drugstores

THOMSON REUTERS
·
Yesterday

elf Beauty Is Maintained at Outperform by Baird

Dow Jones
·
14 May

Elf Beauty price target raised to $100 from $85 at Baird

TIPRANKS
·
14 May

Retail Stocks Jump on Lower China Tariffs. It Isn't the 'All Clear' Yet. -- Barrons.com

Dow Jones
·
12 May

BUZZ-US retailers rise after US, China agree to ease some tariffs for 90 days

Reuters
·
12 May

Shares of Beauty Cos up After US, China Agree to Cut Tariffs, 90-Day Pause

THOMSON REUTERS
·
12 May

elf Beauty Jumps 13%, Ulta Beauty up 6.1% and Coty Rises 8.1%

THOMSON REUTERS
·
12 May

e.l.f. Cosmetics Unleashes "The Many-Trick Pony" Because No One Puts Halo Glow in a Box

Business Wire
·
01 May

elf Beauty Is Maintained at Overweight by Piper Sandler

Dow Jones
·
01 May

Is e.l.f. Beauty (ELF) A Stock That Should Double in 3 Years?

Insider Monkey
·
30 Apr

GENFIT: positive late-breaking Phase 2 data for elafibranor in Primary Sclerosing Cholangitis (PSC) to be presented by Ipsen at EASL Congress 2025

GlobeNewswire
·
29 Apr

Jim Cramer on e.l.f. Beauty, Inc. (ELF): ‘I Would Like You To Be In That Stock’

Insider Monkey
·
27 Apr

e.l.f. Beauty (NYSE:ELF) Gains 14% In Share Price Over Last Week

Simply Wall St.
·
25 Apr

elf Beauty Is Maintained at Buy by Truist Securities

Dow Jones
·
25 Apr

e.l.f. is the First Beauty Brand to Launch a Financial Literacy Game on Roblox

Business Wire
·
24 Apr

Late-breaking elafibranor primary sclerosing cholangitis (PSC) data demonstrates favorable safety profile and significant efficacy in second potential rare liver disease indication

GlobeNewswire
·
24 Apr

U.S. RESEARCH ROUNDUP-Amazon, Comerica, United Airlines

Reuters
·
22 Apr